Table 1.

Oligodeoxynucleotides used in this study.

Name	Sequence	Description
RNDTAG	5′-TAA GGT AGG ACT ACG NNN NNN NN	RT-ROL random tagged oligonucleotide
TAG	5′-TAA GGT AGG ACT ACG	RT-ROL amplification oligonucleotide
sRODRNA	5′-GGT CGC TCT GCG GAG AGG CTG	detection oligonucleotide for 5′ end of viral RNA
sROD145	5′-CCT CTT AAT AAA GCT GCC AG	detection oligonucleotide for the 145 region of viral RNA
sROD 228	5′-CCT GAG TAA CAA GAC CCT GG	detection oligonucleotide for 228 region of viral RNA
asROD32	5′-GCT CAA TCT GCC AG	antisense oligonucleotide complementary to 32 region of viral RNA
asROD99	5′-GTG CTG GTG AGA CTC TAG CAG	antisense oligonucleotide complementary to 99 region of viral RNA
asROD172	5′-GCT TCT AAC TGG C	antisense oligonucleotide complementary to 172 region of viral RNA
asROD258	5′-GTC CTA ACA GAC CAG G	antisense oligonucleotide complementary to 258 region of viral RNA
asROD309	5′-GGC GCC AAC CTG CTA GGG ATT	antisense oligonucleotide complementary to 309 region of viral RNA
asRODPBS	5′-GTC CCT GTT CAG GCG CCA	antisense oligonucleotide complementary to the 18nt PBS sequence
asROD344	5′-CCA AGA CTT CTC AGT CTT C	antisense oligonucleotide complementary to 344 region of viral RNA
asROD418	5′-CGG CCC GCG CCT TTC TAG	control oligonucleotide not complementary to any region of 1-381 RNA